Wafik S. El-Deiry: Lobbying congress to make cancer funding a priority
Wafik S. El-Deiry shared a post on Linkedin:
” I am reminded of the first time I went to advocate for NIH funding in 2006. I’ll share this editorial I wrote about the experience so that more of my colleagues step up and become more active for change.
Many issues have not changed in nearly 20 years but I do believe that some day the government will listen and more highly prioritize research funding in the US.
Lobbying congress to make cancer funding a priority: What scientists can do.”
Lobbying congress to make cancer funding a priority: What scientists can do
Author: Wafik S. El-Deiry
Additional information.
Source: Wafik S. El-Deiry/Linkedin
Wafik S. El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals. He is the Editor in Chief at Oncotarget. Dr. El-Deiry discovered p21(WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response. Dr. El-Deiry’s research is focused on mechanisms of therapy resistance with major efforts in drug discovery and development.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023